Sort
23,748 grants matching “melanoma”
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$572,202Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2023 · CA
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
$572,160Mary L. Disis · University Of Washington · R01 · FY2010 · CA
The Antiproliferative Activities of Human Interferons
$571,998Kathryn Zoon · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Identifying Therapeutic Targets for Stage III Melanoma
$571,965Anand K Ganesan · University Of California-Irvine · R01 · FY2022 · CA
Ultrasonic perfusion imaging of peripheral vascular disease
$571,833Michael F Insana · University Of Illinois At Urbana-Champaign · R01 · FY2020 · HL
In vivo Clinical Coherence Confocal Microscope
$571,661James M Zavislan · Lucid, Inc. · R42 · FY2007 · CA
Molecular and Functional Analysis of Innate Immune Receptors
$571,581Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
Tissue Resident memory T cell responses to cancer
$571,578Mary J Turk · Dartmouth College · R01 · FY2025 · CA
Combating melanoma resistance by targeting ABL1/2
$571,489Rina Plattner · University Of Kentucky · R01 · FY2023 · CA
Administrative Core
$571,463Raymond E Samuel · Hampton University · U54 · FY2016 · MD
Elucidating the Role of Cancer-Associated FGL1 in Tumor Immunity and Developing FGL1-Guided Anti-LAG-3 Cancer Immunotherapy
$571,456Jun Wang · New York University School Of Medicine · R37 · FY2025 · CA
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma
$571,434David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2015 · CA
Progressive acquisition of novel neural crest derivatives along the neural axis during vertebrate evolution
$571,326Marianne Bronner-Fraser · California Institute Of Technology · R35 · FY2023 · NS
Progressive acquisition of novel neural crest derivatives along the neural axis during vertebrate evolution
$571,326Marianne Bronner-Fraser · California Institute Of Technology · R35 · FY2020 · NS
Progressive acquisition of novel neural crest derivatives along the neural axis during vertebrate evolution
$571,326Marianne Bronner-Fraser · California Institute Of Technology · R35 · FY2022 · NS
Progressive acquisition of novel neural crest derivatives along the neural axis during vertebrate evolution
$571,326Marianne Bronner-Fraser · California Institute Of Technology · R35 · FY2021 · NS
Role of IRF2 in cancer immune evasion and immunotherapy
$571,214Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$571,214Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Overcoming Immunotherapy Resistance Through Opioid Antagonism in Head and Neck Cancer
$571,177Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
Phase II Clinical Development of Galectin-3 Inhibition and Anti-PD-1: Immune Monitoring and Tumor Response
$571,136Brendan D Curti · Providence Portland Medical Center · R01 · FY2024 · CA
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
$570,958Brinda Emu · Yale University · R01 · FY2018 · CA
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons
$570,918Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2013 · CA
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$570,868Efstathios Karathanasis · Case Western Reserve University · R01 · FY2024 · CA
A personalized approach to skin cancer prevention among adolescents
$570,717Yelena Ping Wu · University Of Utah · R01 · FY2024 · CA
Transcriptional heterogeneity and regulatory mechanisms in tumor microenvironment
$570,593Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA